Health

Daewoong Therapeutics Microneedle Patch Achieves Best-in-Class Bioavailability, Proving the Strength of Its Drug-Delivery Platform

* More than 80% relative bioavailability compared with injectable obesity therapy, well above the roughly 30% reported for existing microneedle patches and setting a new global benchmark * A potential game changer that addresses both the pain of injections and the low efficiency of oral form...

2025-08-13 15:36 1500

Hospital Management Asia 2025: Shaping the Future of Asian Healthcare

HO CHI MINH CITY, Vietnam, Aug. 13, 2025 /PRNewswire/ -- Hospital Management Asia (HMA) , the region's premier annual event for hospital management and healthcare, is set to officially take place at GEM Center,Ho Chi Minh City. This year's conference,...

2025-08-13 15:19 1861

Prince Court Medical Centre Strengthens Malaysia's Position as a Global Healthcare Destination with First Kelly Procedure

KUALA LUMPUR, Malaysia, Aug. 13, 2025 /PRNewswire/ -- Prince Court Medical Centre has placedMalaysia firmly on the global medical tourism map by successfully performing the country's first Kelly procedure, an advanced reconstructive surgery for rare congenital urological conditions.

2025-08-13 15:16 1983

KBP's Contest of Injunction Obtained by Novo Nordisk Continues in Arbitration

SINGAPORE, Aug. 13, 2025 /PRNewswire/ -- KBP Biosciences Pte. Ltd. (the "Company ") today issued a statement addressing a further decision by the Singapore International Commercial Court (the "Court") to maintain the temporary injunction against the Company and its founder, Dr. Huang Zhenhua ("Dr....

2025-08-13 09:44 4438

Second heartbeat

BEIJING, Aug. 12, 2025 /PRNewswire/ -- A news report from chinadaily.com.cn In this documentary, three patients suffered from advanced heart failure share their stories of howChina's independently-developed non-contact full maglev artificial heart brought hope to their lives. Click to learn more!...

2025-08-13 09:34 2343

Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, Demonstrated Greater Efficacy with Tirzepatide than Semaglutide in a Preclinical Model

-         The combination of ASC47 low dose with tirzepatide in diet-induced obese (DIO) mice resulted in an 87% greater reduction in body weight compared to tirzepatide monotherapy.  -          ASC47 low dose in combination with tirzepatide demonstrated statistically significantly greater incre...

2025-08-13 07:00 1692

MindHYVE.ai Partners with ICS Pakistan and NEI Pakistan to Revolutionize Nursing Education with AI-Powered ArthurAI

ISLAMABAD, Aug. 13, 2025 /PRNewswire/ --In a pioneering step towards elevating nursing education inPakistan, MindHYVE.ai has signed strategic Memorandum of Understanding (MoU) with the Institute of Contemporary Studies (ICS) and the National Excellence Institute (NEI).

2025-08-13 06:00 1634

VivaVision Strengthens Scientific Advisory Board with a World-Renowned Expert in Ophthalmology

WENZHOU, China, Aug. 12, 2025 /PRNewswire/ -- Recently, VivaVision Biotech ( Zhejiang) Co., Ltd. (VivaVision) announced the appointment of Quan Dong Nguyen, MD, MSc, FAAO, FARVO, FASRS to its Scientific Advisory Board. Quan Dong Nguyen, MD, MSc, FAAO, FARVO, FASRS, is currently a professor of oph...

2025-08-13 00:00 1804

Mabwell Announces First Patient Dosed in the US Clinical Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated with ADCs

SHANGHAI, Aug. 12, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced the first patient dosing in the U.S. for a clinical study of its novel nectin-4-targeting antibody-drug conjugate (Bulumtatug Fuvedotin, or BFv, R&D code: 9MW...

2025-08-12 22:00 1809

Aquedeon Medical Inc. Receives FDA Approval to Expand Clinical Trial of Duett Vascular Graft System

CAUTION: Investigational device. Limited by Federal (or United States) law to investigational use. SUNNYVALE, Calif., Aug. 12, 2025 /PRNewswire/ -- Aquedeon Medical Inc. (AMI) is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved the expansion of its Investigationa...

2025-08-12 20:00 1407

Manipal Hospitals Kolkata completes 50 successful TAVR cases

KOLKATA, India, Aug. 12, 2025 /PRNewswire/ -- Manipal Hospitals - EM Bypass (erstwhile Medica Superspecialty Hospital),Kolkata is thrilled to announce the completion of50 successful Transcatheter Aortic Valve Replacement (TAVR) cases, establishing the facility as a regional market leader in struc...

2025-08-12 17:29 1475

WuXi Biologics' WuXiUP™ Accomplishes Automated Continuous Drug Substance Production at Pilot-Scale

* Building on its success in developing continuous production at pilot-scale with the WuXiUP™ platform, WuXi Biologics has further enhanced the technology to achieve automated continuous drug substance (DS) manufacturing at pilot-scale. This advancement integrates industry-leading technologies,...

2025-08-12 17:00 1934

For everyone with sensitive skin: Understanding skin science with Cetaphil and its new innovative product

KUALA LUMPUR, Malaysia, Aug. 12, 2025 /PRNewswire/ -- Cetaphil®, the trusted global leader in sensitive skincare and the No. 1 dermatological skincare brand inMalaysia*, announced a transformative rebrand with a bold shift towards an advocacy-first strategy. This new approach was unveiled at the ...

2025-08-12 16:23 2198

Life (Insurance) starts at 30 - when Aussies wish they'd signed up for coverage

BRISBANE, Australia, Aug. 12, 2025 /PRNewswire/ -- One quarter of Australians with life insurance wish they'd taken out their policy earlier in life, according to a newBudget Direct Life Insurance survey

2025-08-12 12:03 1500

Fosun Pharma's Small Molecule Innovative Drug XH-S004 Achieves Overseas Licensing for a Potential Total of $645 Million

SHANGHAI, Aug. 11, 2025 /PRNewswire/ -- On August 11, Fosun Pharma (SSE:600196, HKEX: 02196) announced that its subsidiary Fosun Pharma Industrial has signed a License Agreement withExpedition Therapeutics Inc.(Expedition) to grant Expedition the rights to develop, manufacture, and commercialize ...

2025-08-12 09:36 1588

Intas & Accord signs Agreement to acquire Prothya Biosolutions

AHMEDABAD, India, Aug. 11, 2025 /PRNewswire/ -- Accord Plasma B.V., a subsidiary of Intas Pharmaceuticals, has announced the execution of an agreement to acquire 100% of Prothya Biosolutions Belgium BV and each of its subsidiaries, a leading plasma-derived medicinal products (PDMP) business based...

2025-08-11 21:41 2651

AGEBOX Presents iKids-Growth: Pioneering Safe and Natural Support for Children's Height Development

RICHMOND, VA., Aug. 11, 2025 /PRNewswire/ -- In the field of pediatric development, a significant advancement is taking shape. For years, parents have navigated a marketplace of nutritional aids—from basic multivitamins to protein powders—with little more than hope to guide them. iKids-Growth mar...

2025-08-11 21:30 1520

Caliber Enters 25th Year of Empowering Global Pharma with GxP Digital Solutions

HYDERABAD, India, Aug. 11, 2025 /PRNewswire/ -- Caliber, a leading global provider of GxP-compliant digital solutions for the life sciences industry, proudly announces the start of its 25th year of operations. Caliber st...

2025-08-11 21:22 2821

EVERISE STRENGTHENS LEADERSHIP TEAM WITH CHIEF REVENUE OFFICER AND CHIEF FINANCIAL OFFICER APPOINTMENTS

PLANTATION, Fla., Aug. 11, 2025 /PRNewswire/ -- Everise, a global leader in transforming customer experiences, today announced two senior leadership appointments as the company continues its growth trajectory and expansion in global markets. Industry veteranRobert Jimenez joins as Chief Revenue O...

2025-08-11 21:00 2598

REVEALING STUDY HAS REJUVANT LEADING THE LONGEVITY PACK

Renowned Longevity Researcher Reveals Highlights of New Study to NBJ Conference Guests FERNANDINA BEACH, Fla., Aug. 11, 2025 /PRNewswire/ -- Dr. Brian Kennedy, one of the world's leading Longevity researchers, gave a keynote presentation at the Nutritional Business Journal's annual CEO conferenc...

2025-08-11 20:06 1538
1 ... 69707172737475 ... 872